Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Lesinurad monotherapy in gout patients intolerant to a xanthine oxidase inhibitor: a 6 month phase 3 clinical trial and extension study.

Tausche AK, Alten R, Dalbeth N, Kopicko J, Fung M, Adler S, Bhakta N, Storgard C, Baumgartner S, Saag K.

Rheumatology (Oxford). 2017 Dec 1;56(12):2170-2178. doi: 10.1093/rheumatology/kex350.

PMID:
29029210
2.

[Evidence-based recommendations for diagnostics and treatment of gouty arthritis in the specialist sector : S2e guidelines of the German Society of Rheumatology in cooperation with the AWMF].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüsslein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche AK, Braun J.

Z Rheumatol. 2017 Mar;76(2):118-124. doi: 10.1007/s00393-016-0249-1. Review. German.

PMID:
28078432
3.

Survey Definitions of Gout for Epidemiologic Studies: Comparison With Crystal Identification as the Gold Standard.

Dalbeth N, Schumacher HR, Fransen J, Neogi T, Jansen TL, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Cimmino MA, Uhlig T, Taylor WJ.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1894-1898. doi: 10.1002/acr.22896. Epub 2016 Oct 28.

4.

Performance of Ultrasound in the Diagnosis of Gout in a Multicenter Study: Comparison With Monosodium Urate Monohydrate Crystal Analysis as the Gold Standard.

Ogdie A, Taylor WJ, Neogi T, Fransen J, Jansen TL, Schumacher HR, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Cagnotto G, Cavagna L, Lin C, Chou YY, Tausche AK, Lima Gomes Ochtrop M, Janssen M, Chen JH, Slot O, Lazovskis J, White D, Cimmino MA, Uhlig T, Dalbeth N.

Arthritis Rheumatol. 2017 Feb;69(2):429-438. doi: 10.1002/art.39959.

5.

[Gouty arthritis].

Tausche AK, Aringer M.

Z Rheumatol. 2016 Nov;75(9):885-898. Review. German.

PMID:
27730304
6.

Validation of Standardized Questionnaires Evaluating Symptoms of Depression in Rheumatoid Arthritis Patients: Approaches to Screening for a Frequent Yet Underrated Challenge.

Englbrecht M, Alten R, Aringer M, Baerwald CG, Burkhardt H, Eby N, Fliedner G, Gauger B, Henkemeier U, Hofmann MW, Kleinert S, Kneitz C, Krueger K, Pohl C, Roske AE, Schett G, Schmalzing M, Tausche AK, Peter Tony H, Wendler J.

Arthritis Care Res (Hoboken). 2017 Jan;69(1):58-66. doi: 10.1002/acr.23002.

7.

Heart-type fatty acid-binding protein and myocardial creatine kinase enable rapid risk stratification in normotensive patients with pulmonary embolism.

Langer M, Forkmann M, Richter U, Tausche AK, Sveric K, Christoph M, Ibrahim K, Günther M, Kolschmann S, Boscheri A, Barthel P, Strasser RH, Wunderlich C.

J Crit Care. 2016 Oct;35:174-9. doi: 10.1016/j.jcrc.2016.05.014. Epub 2016 May 26.

PMID:
27481755
8.

[Full version of the S2e guidelines on gouty arthritis : Evidence-based guidelines of the German Society of Rheumatology (DGRh)].

Kiltz U, Alten R, Fleck M, Krüger K, Manger B, Müller-Ladner U, Nüßlein H, Reuss-Borst M, Schwarting A, Schulze-Koops H, Tausche A, Braun J.

Z Rheumatol. 2016 Aug;75 Suppl 2:11-60. doi: 10.1007/s00393-016-0147-6. Review. German. No abstract available.

PMID:
27481119
9.

2016 updated EULAR evidence-based recommendations for the management of gout.

Richette P, Doherty M, Pascual E, Barskova V, Becce F, Castañeda-Sanabria J, Coyfish M, Guillo S, Jansen TL, Janssens H, Lioté F, Mallen C, Nuki G, Perez-Ruiz F, Pimentao J, Punzi L, Pywell T, So A, Tausche AK, Uhlig T, Zavada J, Zhang W, Tubach F, Bardin T.

Ann Rheum Dis. 2017 Jan;76(1):29-42. doi: 10.1136/annrheumdis-2016-209707. Epub 2016 Jul 25. Review.

PMID:
27457514
10.

[Inflammasome and gout].

Aringer M, Hedrich C, Tausche AK.

Z Rheumatol. 2016 Aug;75(6):537-41. doi: 10.1007/s00393-016-0131-1. Review. German. No abstract available.

PMID:
27418053
11.

Replication of association of the apolipoprotein A1-C3-A4 gene cluster with the risk of gout.

Rasheed H, Phipps-Green AJ, Topless R, Smith MD, Hill C, Lester S, Rischmueller M, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, van Rij A, Jones GT, McCormick SP, Harrison AA, Stamp LK, Dalbeth N, Merriman TR.

Rheumatology (Oxford). 2016 Aug;55(8):1421-30. doi: 10.1093/rheumatology/kew057. Epub 2016 Apr 18.

PMID:
27094595
12.

The Toll-Like Receptor 4 (TLR4) Variant rs2149356 and Risk of Gout in European and Polynesian Sample Sets.

Rasheed H, McKinney C, Stamp LK, Dalbeth N, Topless RK, Day R, Kannangara D, Williams K, Smith M, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, Lu L, Stahl EA, Choi HK, So A, Merriman TR.

PLoS One. 2016 Jan 25;11(1):e0147939. doi: 10.1371/journal.pone.0147939. eCollection 2016.

13.

[Do we still need clinical studies in rheumatology?].

Henkemeier U, Alten R, Bannert B, Baraliakos X, Behrens F, Heldmann F, Kiltz U, Köhm M, König R, Leipe J, Müller-Ladner U, Rech J, Riechers E, Rubbert-Roth A, Schmidt RE, Schulze-Koops H, Specker C, Tausche AK, Wassenberg S, Witt M, Witte T, Zernicke J, Burkhardt H.

Z Rheumatol. 2016 Feb;75(1):4-10. doi: 10.1007/s00393-015-1687-x. German.

PMID:
26680367
14.

Diagnostic Arthrocentesis for Suspicion of Gout Is Safe and Well Tolerated.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Ralph Schumacher H, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire CA, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

J Rheumatol. 2016 Jan;43(1):150-3. doi: 10.3899/jrheum.150684. Epub 2015 Dec 1.

PMID:
26628602
15.

Multiplicative interaction of functional inflammasome genetic variants in determining the risk of gout.

McKinney C, Stamp LK, Dalbeth N, Topless RK, Day RO, Kannangara DR, Williams KM, Janssen M, Jansen TL, Joosten LA, Radstake TR, Riches PL, Tausche AK, Lioté F, So A, Merriman TR.

Arthritis Res Ther. 2015 Oct 13;17:288. doi: 10.1186/s13075-015-0802-3.

16.

Development of Preliminary Remission Criteria for Gout Using Delphi and 1000Minds Consensus Exercises.

de Lautour H, Taylor WJ, Adebajo A, Alten R, Burgos-Vargas R, Chapman P, Cimmino MA, da Rocha Castelar Pinheiro G, Day R, Harrold LR, Helliwell P, Janssen M, Kerr G, Kavanaugh A, Khanna D, Khanna PP, Lin C, Louthrenoo W, McCarthy G, Vazquez-Mellado J, Mikuls TR, Neogi T, Ogdie A, Perez-Ruiz F, Schlesinger N, Ralph Schumacher H, Scirè CA, Singh JA, Sivera F, Slot O, Stamp LK, Tausche AK, Terkeltaub R, Uhlig T, van de Laar M, White D, Yamanaka H, Zeng X, Dalbeth N.

Arthritis Care Res (Hoboken). 2016 May;68(5):667-72. doi: 10.1002/acr.22741.

17.

Milk Fat Globule-Epidermal Growth Factor 8 (MFG-E8) Is a Novel Anti-inflammatory Factor in Rheumatoid Arthritis in Mice and Humans.

Albus E, Sinningen K, Winzer M, Thiele S, Baschant U, Hannemann A, Fantana J, Tausche AK, Wallaschofski H, Nauck M, Völzke H, Grossklaus S, Chavakis T, Udey MC, Hofbauer LC, Rauner M.

J Bone Miner Res. 2016 Mar;31(3):596-605. doi: 10.1002/jbmr.2721. Epub 2015 Nov 9.

18.

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vaquez-Mellado J, Yarows SA, Taylor WJ.

Ann Rheum Dis. 2015 Oct;74(10):1789-98. doi: 10.1136/annrheumdis-2015-208237. Erratum in: Ann Rheum Dis. 2016 Feb;75(2):473.

19.

2015 Gout Classification Criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, Fransen J, Schumacher HR, Berendsen D, Brown M, Choi H, Edwards NL, Janssens HJ, Lioté F, Naden RP, Nuki G, Ogdie A, Perez-Ruiz F, Saag K, Singh JA, Sundy JS, Tausche AK, Vazquez-Mellado J, Yarows SA, Taylor WJ.

Arthritis Rheumatol. 2015 Oct;67(10):2557-68. doi: 10.1002/art.39254. Erratum in: Arthritis Rheumatol. 2016 Feb;68(2):515. Vaquez-Mellado, Janitzia [corrected to Vazquez-Mellado, Janitzia].

20.

Study for Updated Gout Classification Criteria: Identification of Features to Classify Gout.

Taylor WJ, Fransen J, Jansen TL, Dalbeth N, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, Vargas-Santos AB, Janssen M, Chen JH, Slot O, Cimmino MA, Uhlig T, Neogi T.

Arthritis Care Res (Hoboken). 2015 Sep;67(9):1304-15. doi: 10.1002/acr.22585.

21.

Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia.

Reuss-Borst MA, Pape CA, Tausche AK.

Springerplus. 2014 Oct 9;3:592. doi: 10.1186/2193-1801-3-592. eCollection 2014.

22.

Performance of classification criteria for gout in early and established disease.

Taylor WJ, Fransen J, Dalbeth N, Neogi T, Schumacher HR, Brown M, Louthrenoo W, Vazquez-Mellado J, Eliseev M, McCarthy G, Stamp LK, Perez-Ruiz F, Sivera F, Ea HK, Gerritsen M, Scire C, Cavagna L, Lin C, Chou YY, Tausche AK, da Rocha Castelar-Pinheiro G, Janssen M, Chen JH, Slot O, Cimmino M, Uhlig T, Jansen TL.

Ann Rheum Dis. 2016 Jan;75(1):178-82. doi: 10.1136/annrheumdis-2014-206364. Epub 2014 Oct 28.

PMID:
25351521
23.

Urate lowering therapy with febuxostat in daily practice-a multicentre, open-label, prospective observational study.

Tausche AK, Reuss-Borst M, Koch U.

Int J Rheumatol. 2014;2014:123105. doi: 10.1155/2014/123105. Epub 2014 Sep 3.

24.

[Chondrocalcinosis due to calcium pyrophosphate deposition (CPPD). From incidental radiographic findings to CPPD crystal arthritis].

Tausche AK, Aringer M.

Z Rheumatol. 2014 May;73(4):349-57; quiz 358-9. doi: 10.1007/s00393-014-1364-5. Review. German.

PMID:
24811359
25.

As compared to allopurinol, urate-lowering therapy with febuxostat has superior effects on oxidative stress and pulse wave velocity in patients with severe chronic tophaceous gout.

Tausche AK, Christoph M, Forkmann M, Richter U, Kopprasch S, Bielitz C, Aringer M, Wunderlich C.

Rheumatol Int. 2014 Jan;34(1):101-9. doi: 10.1007/s00296-013-2857-2. Epub 2013 Sep 12.

PMID:
24026528
26.

A 3-day delay in synovial fluid crystal identification did not hinder the reliable detection of monosodium urate and calcium pyrophosphate crystals.

Tausche AK, Gehrisch S, Panzner I, Winzer M, Range U, Bornstein SR, Siegert G, Wunderlich C, Aringer M.

J Clin Rheumatol. 2013 Aug;19(5):241-5. doi: 10.1097/RHU.0b013e31829cde53.

PMID:
23872540
27.

Dexrazoxane prevents the development of the impaired cardiac phenotype in caveolin-1-disrupted mice.

Polanski AK, Ebner A, Ebner B, Hofmann A, Steinbronn N, Brandt A, Forkmann M, Tausche AK, Morawietz H, Strasser RH, Wunderlich C.

J Cardiovasc Pharmacol. 2013 Jun;61(6):545-52. doi: 10.1097/FJC.0b013e31828de47c.

PMID:
23474841
28.

The devil bites his joints--severe tophaceous gout.

Tausche AK.

J Clin Rheumatol. 2012 Oct;18(7):375. doi: 10.1097/RHU.0b013e31826d27c6. No abstract available.

PMID:
23047539
29.

Tophi and frequent gout flares are associated with impairments to quality of life, productivity, and increased healthcare resource use: Results from a cross-sectional survey.

Khanna PP, Nuki G, Bardin T, Tausche AK, Forsythe A, Goren A, Vietri J, Khanna D.

Health Qual Life Outcomes. 2012 Sep 22;10:117. doi: 10.1186/1477-7525-10-117.

30.

[Gout as a systemic disease. Manifestations, complications and comorbidities of hyperuricaemia].

Tausche AK, Manger B, Müller-Ladner U, Schmidt B.

Z Rheumatol. 2012 Apr;71(3):224-30. doi: 10.1007/s00393-011-0953-9. German.

PMID:
22415625
31.

"To be or not to be," ten years after: evidence for mixed connective tissue disease as a distinct entity.

Cappelli S, Bellando Randone S, Martinović D, Tamas MM, Pasalić K, Allanore Y, Mosca M, Talarico R, Opris D, Kiss CG, Tausche AK, Cardarelli S, Riccieri V, Koneva O, Cuomo G, Becker MO, Sulli A, Guiducci S, Radić M, Bombardieri S, Aringer M, Cozzi F, Valesini G, Ananyeva L, Valentini G, Riemekasten G, Cutolo M, Ionescu R, Czirják L, Damjanov N, Rednic S, Matucci Cerinic M.

Semin Arthritis Rheum. 2012 Feb;41(4):589-98. doi: 10.1016/j.semarthrit.2011.07.010. Epub 2011 Sep 29.

PMID:
21959290
32.

[Gout - regardless of therapeutic options a "forgotten" disease].

Müller-Ladner U, Panzner I, Kriegsmann J, Lange U, Tausche AK.

Dtsch Med Wochenschr. 2011 Aug;136(33):1660-4. doi: 10.1055/s-0031-1281570. Epub 2011 Aug 10. Review. German.

PMID:
21833886
33.

Tophaceous gout and renal insufficiency: a new solution for an old therapeutic dilemma.

Tausche AK, Wunderlich C, Aringer M.

Case Rep Med. 2011;2011:397646. doi: 10.1155/2011/397646. Epub 2011 May 14.

34.

Disabling gout.

Tausche AK, Panzner I, Aust D, Wunderlich C.

Lancet. 2010 Sep 25;376(9746):1093. doi: 10.1016/S0140-6736(10)60135-3. Epub 2010 Sep 16. No abstract available.

PMID:
20843547
35.

International position paper on febuxostat.

Jansen TL, Richette P, Perez-Ruiz F, Tausche AK, Guerne PA, Punzi L, Leeb B, Barskova V, Uhlig T, Pimentão J, Zimmermann-Górska I, Pascual E, Bardin T, Doherty M.

Clin Rheumatol. 2010 Aug;29(8):835-40. doi: 10.1007/s10067-010-1457-8. Epub 2010 Apr 17. Review.

PMID:
20401506
36.

[Crystal-induced activation of the inflammasome: gout and pseudogout].

Winzer M, Tausche AK, Aringer M.

Z Rheumatol. 2009 Nov;68(9):733-9. doi: 10.1007/s00393-009-0489-4. German.

PMID:
19838718
37.

Gout--current diagnosis and treatment.

Tausche AK, Jansen TL, Schröder HE, Bornstein SR, Aringer M, Müller-Ladner U.

Dtsch Arztebl Int. 2009 Aug;106(34-35):549-55. doi: 10.3238/arztebl.2009.0549. Epub 2009 Aug 24. Review.

38.

Eisenmenger's syndrome.

Wunderlich C, Wunderlich O, Tausche AK, Strasser RH.

Intern Med J. 2009 Jul;39(7):485. doi: 10.1111/j.1445-5994.2009.01937.x. No abstract available.

PMID:
19664160
39.

The adverse cardiopulmonary phenotype of caveolin-1 deficient mice is mediated by a dysfunctional endothelium.

Wunderlich C, Schober K, Schmeisser A, Heerwagen C, Tausche AK, Steinbronn N, Brandt A, Kasper M, Schwencke C, Braun-Dullaeus RC, Strasser RH.

J Mol Cell Cardiol. 2008 May;44(5):938-47. doi: 10.1016/j.yjmcc.2008.02.275. Epub 2008 Mar 8.

PMID:
18417152
40.

The Janus faces of allopurinol-allopurinol hypersensitivity syndrome.

Tausche AK, Aringer M, Schroeder HE, Bornstein SR, Wunderlich C, Wozel G.

Am J Med. 2008 Mar;121(3):e3-4. doi: 10.1016/j.amjmed.2007.10.028. No abstract available.

PMID:
18328291
41.

[Molecular basis of primary renal hyperuricemia : role of the human urate transporter hURAT1].

Unger S, Tausche AK, Kopprasch S, Bornstein SR, Aringer M, Grässler J.

Z Rheumatol. 2007 Nov;66(7):556, 58-61. German.

PMID:
17891408
42.

Retrieval of two retained endoscopy capsules with retrograde double-balloon enteroscopy in a patient with a history of complicated small-bowel disease.

Miehlke S, Tausche AK, Brückner S, Aust D, Morgner A, Madisch A.

Endoscopy. 2007 Feb;39 Suppl 1:E157. Epub 2006 Jul 18. No abstract available.

PMID:
17570097
43.

Ortner's syndrome or cardiovocal hoarseness.

Wunderlich C, Wunderlich O, Tausche AK, Fuhrmann J, Boscheri A, Strasser RH.

Intern Med J. 2007 Jun;37(6):418-9. No abstract available.

PMID:
17535390
44.

Gout--new insights into a forgotten disease.

Graessler J, Unger S, Tausche AK, Kopprasch S, Bornstein SR.

Horm Metab Res. 2006 Mar;38(3):203-4. No abstract available.

PMID:
16673214
46.

[Hyperuricemia and gout: diagnosis and therapy].

Tausche AK, Unger S, Richter K, Wunderlich C, Grässler J, Roch B, Schröder HE.

Internist (Berl). 2006 May;47(5):509-20; quiz 521. German.

PMID:
16586130
47.

Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population.

Graessler J, Graessler A, Unger S, Kopprasch S, Tausche AK, Kuhlisch E, Schroeder HE.

Arthritis Rheum. 2006 Jan;54(1):292-300.

48.

Anti-midbody antibodies as a possible predictive factor for a special limited or abortive form of systemic sclerosis?

Tausche AK, Conrad K, Seidel W, Roch B.

Ann Rheum Dis. 2005 Aug;64(8):1237-8. No abstract available.

49.

Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti-tumour necrosis factor alpha as a new therapeutic option.

Tausche AK, Richter K, Grässler A, Hänsel S, Roch B, Schröder HE.

Ann Rheum Dis. 2004 Oct;63(10):1351-2. No abstract available.

50.

Case number 31: Nodular panniculitis as expression of Munchausen's syndrome (panniculitis artefacta).

Tausche AK, Hänsel S, Tausche K, Unger S, Schröder HE, Pietsch J.

Ann Rheum Dis. 2004 Oct;63(10):1195-6. No abstract available.

Supplemental Content

Loading ...
Support Center